Search Results - "Marrie, RA"

Refine Results
  1. 1

    The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated by Marrie, RA, Horwitz, R, Cutter, G, Tyry, T, Campagnolo, D, Vollmer, T

    Published in Multiple sclerosis (01-03-2009)
    “…Background Mental comorbidity is common in multiple sclerosis (MS), but some studies suggest that mental comorbidity may be underrecognized and undertreated…”
    Get full text
    Journal Article
  2. 2

    Environmental risk factors in multiple sclerosis aetiology by Marrie, Ruth Ann

    Published in Lancet neurology (01-12-2004)
    “…The epidemiology of multiple sclerosis (MS) has been intensively studied. It is conceptualised as a complex disease in which genetic and environmental factors…”
    Get more information
    Journal Article
  3. 3
  4. 4

    Effect of comorbidity on mortality in multiple sclerosis by Marrie, Ruth Ann, Elliott, Lawrence, Marriott, James, Cossoy, Michael, Blanchard, James, Leung, Stella, Yu, Nancy

    Published in Neurology (21-07-2015)
    “…OBJECTIVE:We aimed to compare survival in the multiple sclerosis (MS) population with a matched cohort from the general population, and to evaluate the…”
    Get full text
    Journal Article
  5. 5

    Comorbidity is associated with disease activity in MS: Findings from the CombiRx trial by Salter, Amber, Kowalec, Kaarina, Fitzgerald, Kathryn C., Cutter, Gary, Marrie, Ruth Ann

    Published in Neurology (04-08-2020)
    “…OBJECTIVE:To determine whether comorbidity is associated with clinical (relapses, disability worsening) and MRI outcomes in multiple sclerosis (MS), we…”
    Get full text
    Journal Article
  6. 6

    Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations by Salter, Amber, Lancia, Samantha, Kowalec, Kaarina, Fitzgerald, Kathryn C, Marrie, Ruth Ann

    Published in Neurology (12-03-2024)
    “…Comorbidity is common in multiple sclerosis (MS) with the most prevalent conditions being depression, anxiety, hypertension, and hyperlipidemia. Limited…”
    Get full text
    Journal Article
  7. 7

    Health-related quality of life in multiple sclerosis: Direct and indirect effects of comorbidity by Berrigan, Lindsay I, Fisk, John D, Patten, Scott B, Tremlett, Helen, Wolfson, Christina, Warren, Sharon, Fiest, Kirsten M, McKay, Kyla A, Marrie, Ruth Ann

    Published in Neurology (12-04-2016)
    “…OBJECTIVE:To evaluate the direct and indirect influences of physical comorbidity, symptoms of depression and anxiety, fatigue, and disability on health-related…”
    Get full text
    Journal Article
  8. 8

    Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study by Kowalec, Kaarina, McKay, Kyla A, Patten, Scott B, Fisk, John D, Evans, Charity, Tremlett, Helen, Marrie, Ruth Ann

    Published in Neurology (12-12-2017)
    “…OBJECTIVE:To evaluate the association between comorbidity and relapse rate in individuals with multiple sclerosis (MS). METHODS:We recruited individuals with…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Etiology, effects and management of comorbidities in multiple sclerosis: recent advances by Marrie, Ruth Ann, Fisk, John D, Fitzgerald, Kathryn, Kowalec, Kaarina, Maxwell, Colleen, Rotstein, Dalia, Salter, Amber, Tremlett, Helen

    Published in Frontiers in immunology (2023)
    “…Comorbid conditions commonly affect people with multiple sclerosis (MS). Population-based studies indicate that people with MS have an increased incidence of…”
    Get full text
    Journal Article
  11. 11

    Incidence and prevalence of multiple sclerosis in Europe: a systematic review by Kingwell, Elaine, Marriott, James J, Jetté, Nathalie, Pringsheim, Tamara, Makhani, Naila, Morrow, Sarah A, Fisk, John D, Evans, Charity, Béland, Sarah Gabrielle, Kulaga, Sophie, Dykeman, Jonathan, Wolfson, Christina, Koch, Marcus W, Marrie, Ruth Ann

    Published in BMC neurology (26-09-2013)
    “…Multiple sclerosis (MS) is the most common cause of neurological disability in young adults worldwide and approximately half of those affected are in Europe…”
    Get full text
    Journal Article
  12. 12

    Validity of performance scales for disability assessment in multiple sclerosis by Marrie, R.A., Goldman, M.

    Published in Multiple sclerosis (01-11-2007)
    “…Researchers increasingly use self-reported health status assessments, but these require validation. Performance Scales (PS) is a self-report measure for…”
    Get full text
    Journal Article
  13. 13

    Incidence rate and prevalence of pediatric-onset multiple sclerosis in Sweden: A population-based register study by Sandesjö, Fredrik, Tremlett, Helen, Fink, Katharina, Marrie, Ruth Ann, Zhu, Feng, Wickström, Ronny, McKay, Kyla A

    Published in European journal of neurology (01-05-2024)
    “…Pediatric-onset multiple sclerosis (PoMS) is associated with high health care use. To plan resource allocation for this patient group, knowledge of the…”
    Get full text
    Journal Article
  14. 14

    Mendelian randomization provides no evidence for a causal role in the bidirectional relationship between depression and multiple sclerosis by Harroud, Adil, Marrie, Ruth Ann, Fitzgerald, Kathryn C, Salter, Amber, Lu, Yi, Patel, Mitulkumar, Kowalec, Kaarina

    Published in Multiple sclerosis (01-11-2021)
    “…Background: Major depressive disorder (MDD) is common in multiple sclerosis (MS) and its incidence rises before MS diagnosis. However, the causality and…”
    Get full text
    Journal Article
  15. 15

    Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study by McKay, Kyla A, Tremlett, Helen, Patten, Scott B, Fisk, John D, Evans, Charity, Fiest, Kirsten, Campbell, Trudy, Marrie, Ruth Ann

    Published in Multiple sclerosis (01-04-2017)
    “…Background: Poor adherence to the disease-modifying therapies (DMTs) for multiple sclerosis (MS) may attenuate clinical benefit. A better understanding of…”
    Get full text
    Journal Article
  16. 16

    Data harmonization for collaborative research among MS registries: A case study in employment by Salter, A, Stahmann, A, Ellenberger, D, Fneish, F, Rodgers, WJ, Middleton, R, Nicholas, R, Marrie, RA

    Published in Multiple sclerosis (01-02-2021)
    “…Objective: To assess the feasibility of collaboration and retrospective data harmonization among three multiple sclerosis (MS) registries by investigating…”
    Get full text
    Journal Article
  17. 17

    Prevalence and Risk Factors of Substance Use Disorder in Inflammatory Bowel Disease by Carney, Heather, Marrie, Ruth Ann, Bolton, James M, Patten, Scott B, Graff, Lesley A, Bernstein, Charles N, Kowalec, Kaarina

    Published in Inflammatory bowel diseases (01-01-2021)
    “…Abstract Background Substance use disorders (SUDs) impose a substantial individual and societal burden; however, the prevalence and associated factors in…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Polygenicity of Comorbid Depression in Multiple Sclerosis by Kowalec, Kaarina, Fitzgerald, Kathryn C., Salter, Amber, Dolovich, Casandra, Harder, Arvid, Bernstein, Charles N., Bolton, James, Cutter, Gary R., Graff, Lesley A., Hägg, Sara, Hitchon, Carol A., Lu, Yi, Lublin, Fred, McKay, Kyla A., Patten, Scott B., Patki, Amit, Tiwari, Hemant K., Wolinsky, Jerry S., Marrie, Ruth Ann

    Published in Neurology (01-08-2023)
    “…Depression is common in multiple sclerosis (MS) and is associated with faster disability progression. The etiology of comorbid depression in MS remains poorly…”
    Get full text
    Journal Article
  20. 20

    Comorbidity, socioeconomic status and multiple sclerosis by Marrie, RA, Horwitz, R, Cutter, G, Tyry, T, Campagnolo, D, Vollmer, T

    Published in Multiple sclerosis (01-09-2008)
    “…Objective Multiple sclerosis (MS) is associated with substantial morbidity. The impact of comorbidity on MS is unknown, but comorbidity may explain some of the…”
    Get full text
    Journal Article